Ambrisentan Hypertension Tablets

nan INR

Get a Price/Quote

Product Details:

Click to view more
Share Your Product:

Request To Call Back Send Inquiry

Ambrisentan Hypertension Tablets Price And Quantity

Minimum Order Quantity 10000000 Piece
Price nan INR

Ambrisentan Hypertension Tablets Trade Information

Payment Terms Cash in Advance (CID) Cash Advance (CA)
Supply Ability 10000000 Piece Per Week
Delivery Time 1 Week
Main Export Market(s) Western Europe Middle East Central America Africa South America Australia Asia Eastern Europe North America

Product Description

Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name pulmonext by MSN labs ) is a drug indicated for use in the treatment of pulmonary hypertension

Ambrisentan was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency, and designated anorphan drug, for the treatment of pulmonary hypertension.